In the media 8 Jul 2026 No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials The Print
In the media 1 Aug 2026 End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment Daily Nation
In the media 30 Jul 2026 WHO approves new shorter, less painful Kala-azar treatment for East Africa New Vision
Viewpoints 30 Jul 2026 Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases Stat News
In the media 15 Jul 2026 Dengue outbreak complicates Bangladesh measles crisis response The Telegraph
Press releases 13 Jul 2026 DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
Press releases 13 Jul 2026 DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals
Scientific articles 9 Jul 2026 Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring PLOS Neglected Tropical Diseases
In the media 9 Jul 2026 Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy The Indian Express
Press Releases Translations 8 Jul 2026 Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia
Press Releases Translations 8 Jul 2026 Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India
Press releases 13 Jul 2026 DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
Press releases 13 Jul 2026 DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals
Press releases 8 Jul 2026 Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India
Press releases 22 Jun 2026 More than 50 organizations urge MEPs to back access provisions in the EU’s next research programme
Press releases 12 Jun 2026 DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness
Press releases 8 Jun 2026 DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
Press releases 4 Mar 2026 Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals
Press releases 27 Feb 2026 Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
Press releases 10 Feb 2026 DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases
Press releases 27 Nov 2025 International seminar explores the development of treatments for dengue for populations not covered by vaccines
Press releases 10 Nov 2025 COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi
Press releases 4 Nov 2025 European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi